EP Patent

EP0592035B1 — Thermostable DNA polymerase composition comprising a temperature sensitive polymerase inhibitor, diagnostic test kits and methods of use

Assigned to Ortho Clinical Diagnostics Inc · Expires 1996-01-03 · 30y expired

What this patent protects

Antibodies which are specific to a thermostable DNA polymerase can be used to reduce or eliminate the formation of non-specific products in polymerase chain reaction methods. These antibodies and other temperature sensitive inhibitors are effective to inhibit DNA polymerase enzym…

USPTO Abstract

Antibodies which are specific to a thermostable DNA polymerase can be used to reduce or eliminate the formation of non-specific products in polymerase chain reaction methods. These antibodies and other temperature sensitive inhibitors are effective to inhibit DNA polymerase enzymatic activity at a certain temperature T1 which is generally below 85<o>C. The inhibitors are irreversibly inactivated at temperature T2 which is generally above 40<o>C. T2 is also greater than T1. Such inhibitors can be supplied individually or in admixture with the DNA polymerase in a diagnostic test kit suitable for PCR. <IMAGE>

Drugs covered by this patent

Patent Metadata

Patent number
EP0592035B1
Jurisdiction
EP
Classification
Expires
1996-01-03
Drug substance claim
No
Drug product claim
No
Assignee
Ortho Clinical Diagnostics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.